Ha Tay Pharmaceutical JSC (HNX:DHT)

Market Cap	6.65T
Revenue (ttm)	2.25T
Net Income (ttm)	66.57B
Shares Out	90.57M
EPS (ttm)	734.97
PE Ratio	99.87
Forward PE	n/a
Dividend	909.09 (1.24%)
Ex-Dividend Date	Oct 30, 2024

Volume	8,200
Average Volume	10,846
Open	72,000
Previous Close	71,900
Day's Range	69,000 - 72,000
52-Week Range	69,000 - 100,818
Beta	0.22
RSI	44.48
Earnings Date	Jan 22, 2026

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment. In addition, the company provides medicinal products manufacturing services; and import-export authorization services, as well as supplies pharmaceutical ingredients for enterprises. The company was founded in 1965 and is based in Hanoi, Vietnam.

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DHT

Financial Performance

In 2024, Ha Tay Pharmaceutical JSC's revenue was 2.09 trillion, an increase of 4.35% compared to the previous year's 2.00 trillion. Earnings were 71.77 billion, a decrease of -15.62%.